Andreas Sutter
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment 12
- Hepatology top 5%
- Physiology top 5%
- Chemical Health and Safety top 10%
-
- Synthesis and pharmacology of benzodiazepine derivatives 6
-
- Molecular Biology Techniques and Applications 6
- DNA Repair Mechanisms 5
- Cancer therapeutics and mechanisms 5
-
- Effects and risks of endocrine disrupting chemicals 5
-
- Neuroscience and Neuropharmacology Research 5
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Hans ScherüblAlexander HuetherMichael HöpfnerKerstin MaaserMartin ZeitzDetlef SchuppanM. ḦopfnerThomas Steger‐Hartmann
- Journals
- Environmental and Molecular Mutagenesis (6 papers)Regulatory Toxicology and Pharmacology (4 papers)Journal of Hepatology (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Andreas Sutter
49 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 375
- Computational Theory and Mathematics 329
- Hepatology 158
- Physiology 72
- Chemical Health and Safety 10
Countries citing papers authored by Andreas Sutter
This map shows the geographic impact of Andreas Sutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Sutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Sutter more than expected).
Fields of papers citing papers by Andreas Sutter
This network shows the impact of papers produced by Andreas Sutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Sutter. The network helps show where Andreas Sutter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andreas Sutter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 14 | |
| 2 | 2020 | 3 | |
| 3 | 2019 | 9 | |
| 4 | 2019 | 32 | |
| 5 | 2018 | 16 | |
| 6 | 2018 | 0 | |
| 7 | 2016 | 15 | |
| 8 | 2015 | 32 | |
| 9 | 2015 | 4 | |
| 10 | 2006 | 97 | |
| 11 | 2005 | 143 | |
| 12 | 2005 | 56 | |
| 13 | 2004 | 143 | |
| 14 | 2004 | 27 | |
| 15 | 2004 | 25 | |
| 16 | 2003 | 32 | |
| 17 | 2003 | 50 | |
| 18 | 2003 | 25 | |
| 19 | 2003 | 70 | |
| 20 | 2002 | 77 |
About Andreas Sutter
Andreas Sutter is a scholar working on Cancer Research, Molecular Biology and Small Animals, having authored 50 papers that have together received 1.8k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (12 papers), Synthesis and pharmacology of benzodiazepine derivatives (6 papers), Molecular Biology Techniques and Applications (6 papers), DNA Repair Mechanisms (5 papers), Cancer therapeutics and mechanisms (5 papers), Effects and risks of endocrine disrupting chemicals (5 papers), Neuroscience and Neuropharmacology Research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Cancer Research (375 citations), Computational Theory and Mathematics (329 citations) and Hepatology (158 citations). Andreas Sutter has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Hans Scherübl, Alexander Huether, Michael Höpfner, Kerstin Maaser, Martin Zeitz, Detlef Schuppan, M. Ḧopfner, Thomas Steger‐Hartmann, Antonius ter Laak and Nikolaus Heinrich. Their work appears in journals such as Environmental and Molecular Mutagenesis, Regulatory Toxicology and Pharmacology, Journal of Hepatology, International Journal of Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.